CP-159 Drug cost avoidance in HIV-1 clinical trials

L Soriano-Irigaray, G Estan-Cerezo, A Andujar-Mateos, FJ Rodriguez-Lucena, R Antón-Torres, A Navarro-Ruiz
  • February 2017, BMJ
  • DOI: 10.1136/ejhpharm-2017-000640.158

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1136/ejhpharm-2017-000640.158

The following have contributed to this page: Francisco Rodriguez-Lucena